BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 1
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (12895)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.
Item 
Count 
PDF912
WORD465
HTML6905
Tables (1-1)192
 Sum=8474
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse574
Download1319
 Sum=1893
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1231
Download1297
 Sum=2528
Feb 15, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Cioffi M, Rosa AD, Serao R, Picone I, Vietri MT. Laboratory markers in ulcerative colitis: Current insights and future advances. World J Gastrointest Pathophysiol 2015; 6(1): 13-22 [PMID: 25685607 DOI: 10.4291/wjgp.v6.i1.13]
URL: https://www.wjgnet.com/1007-9327/full/v6/i1/13.htm
Number Citing Articles
1
Serah Funke Ige, Mayowa J. Adeniyi, Alabi Timilehin Olayinka, Idowu Christiana Kehinde. Role of Dietary Maize Formulations in the Healing of Experimental Acetic Acid Induced Ulcerative Colitis in Male Rats. Chinese Journal of Physiology 2020; 63(4): 156 doi: 10.4103/CJP.CJP_33_20
2
Ruoyu He, Yanfei Wang, Chen Shuang, Chan Xu, Xiaoling Li, Yanfei Cao. Single-cell transcriptomics reveals activation of endothelial cell and identifies LHPP as a potential target in ulcerative colitis. Heliyon 2024; 10(7): e29163 doi: 10.1016/j.heliyon.2024.e29163
3
Stanko Petrovic, Slobodan Obradovic, Marijana Petrovic, Nemanja Rancic. Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy. 2022;  doi: 10.5772/intechopen.102041
4
Mohamed A. Morsy, Sumeet Gupta, Anroop B. Nair, Katharigatta N. Venugopala, Khaled Greish, Mahmoud El-Daly. Protective Effect of Spirulina platensis Extract against Dextran-Sulfate-Sodium-Induced Ulcerative Colitis in Rats. Nutrients 2019; 11(10): 2309 doi: 10.3390/nu11102309
5
Ki-Uk Kim, Jisu Kim, Wan-Hoon Kim, Hyeyoung Min, Chang Hwan Choi. Treatments of inflammatory bowel disease toward personalized medicine. Archives of Pharmacal Research 2021; 44(3): 293 doi: 10.1007/s12272-021-01318-6
6
Nicholas JD Gould, Katharine LM Davidson, Chuka U Nwokolo, Ramesh P Arasaradnam. A systematic review of the role of DNA methylation on inflammatory genes in ulcerative colitis. Epigenomics 2016; 8(5): 667 doi: 10.2217/epi-2016-0006
7
Serena Longo, Marcello Chieppa, Luca G. Cossa, Chiara C. Spinelli, Marco Greco, Michele Maffia, Anna M. Giudetti. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies. Proteomes 2020; 8(3): 18 doi: 10.3390/proteomes8030018
8
Emmanuel A. Adakudugu, Elvis O. Ameyaw, Ernest Obese, Robert P. Biney, Isaac T. Henneh, Douglas B. Aidoo, Elizabeth N. Oge, Isaac Y. Attah, David D. Obiri. Protective effect of bergapten in acetic acid-induced colitis in rats. Heliyon 2020; 6(8): e04710 doi: 10.1016/j.heliyon.2020.e04710
9
Jérémy Allary, Didier Fressard, Guy Malgras, Francine Foubert, Marie Savary. Résistance à l’atracurium et bloc neuromusculaire paradoxal à la néostigmine : description d’un cas clinique. Anesthésie & Réanimation 2017; 3(2): 189 doi: 10.1016/j.anrea.2016.12.001
10
Ghady Rahhal, Mark Levine. Gastrointestinal Emergencies. 2019; : 325 doi: 10.1007/978-3-319-98343-1_94
11
Meng-Hui Zhang, Han Wang, Hong-Gang Wang, Xin Wen, Xiao-Zhong Yang. Effective immune-inflammation index for ulcerative colitis and activity assessments. World Journal of Clinical Cases 2021; 9(2): 334-343 doi: 10.12998/wjcc.v9.i2.334
12
Junxiang Zeng, Xiupan Gao, Wensong Ge, Manxiu Huai, Zhigang Yang, Ting Luo, Limei Gao, Xiujun Pan. Development of a scoring system for predicting the severity of ulcerative colitis. Arab Journal of Gastroenterology 2023; 24(4): 211 doi: 10.1016/j.ajg.2023.07.001
13
Anna Góra, Katarzyna Bąk-Drabik, Jolanta Porębska, Franciszek Halkiewicz, Katarzyna Ziora, Edyta Machura. Trudności w ustaleniu etiologii zmian płucnych u 15-letniej dziewczynki z wrzodziejącym zapaleniem jelita grubego. Pediatria Polska 2017; 92(6): 770 doi: 10.1016/j.pepo.2017.07.002
14
Gabriele Dragoni, Tommaso Innocenti, Andrea Galli. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?. Digestive Diseases 2021; 39(3): 190 doi: 10.1159/000511641
15
Tian Liu, Zhenkun Qin, Zhiyue Yang, Xiaoling Feng. Predictive Value of MHR and NLR for Ulcerative Colitis Disease Activity. International Journal of General Medicine 2024; : 685 doi: 10.2147/IJGM.S446723
16
Yu. M. Stepanov, I. V. Psareva, O. M. Tatarchuk, E. V. Zygalo, O. P. Petishko. LEVELS OF INTESTINAL INFLAMMATION MARKERS AS A DIAGNOSTIC CRITERION FOR FORMING A RISK GROUP FOR IDENTIFICATION OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN ULCER COLIT . Bulletin of Problems Biology and Medicine 2020; 4(2): 204 doi: 10.29254/2077-4214-2019-4-2-154-204-207
17
Angela M. Patterson. Soluble Syndecan-1: Does This Biomarker Address a Seemingly Insoluble Problem in Inflammatory Bowel Disease?. Digestive Diseases and Sciences 2015; 60(8): 2222 doi: 10.1007/s10620-015-3669-x
18
Bruce E. Sands. Biomarkers of Inflammation in Inflammatory Bowel Disease. Gastroenterology 2015; 149(5): 1275 doi: 10.1053/j.gastro.2015.07.003
19
Olga V. Usoltseva, Andrey N. Surkov, Goar B. Movsisyan, Alexander S. Potapov, Elena A. Kulebina, Кirill A. Kulikov, Vladislav V. Chernikov. Correlation of Inflammatory Bowel Diseases with Liver Involvement Severity in Autoimmune Hepatobiliary Pathology: Cross-Sectional Study. Current Pediatrics 2022; 21(2): 105 doi: 10.15690/pf.v19i2.2407
20
Gerda C Leitner, Harald Vogelsang. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 5-20 doi: 10.4292/wjgpt.v7.i1.5
21
Griet Debyser, Bart Mesuere, Lieven Clement, Jens Van de Weygaert, Pieter Van Hecke, Gwen Duytschaever, Maarten Aerts, Peter Dawyndt, Kris De Boeck, Peter Vandamme, Bart Devreese. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis. Journal of Cystic Fibrosis 2016; 15(2): 242 doi: 10.1016/j.jcf.2015.08.003
22
Mayu Uchihara, Jun Kato, Saya Tsuda, Takeichi Yoshida, Takao Maekita, Mikitaka Iguchi, Masayuki Kitano. Blood biomarkers reflect integration of severity and extent of endoscopic inflammation in ulcerative colitis. JGH Open 2017; 1(3): 98 doi: 10.1002/jgh3.12017
23
Olfat G. Shaker, Marwa A. Ali, Tarek I. Ahmed, Othman M. Zaki, Doaa Y. Ali, Essam A. Hassan, Nada F. Hemeda, Marwa N. AbdelHafez. Association between LINC00657 and miR‐106a serum expression levels and susceptibility to colorectal cancer, adenomatous polyposis, and ulcerative colitis in Egyptian population. IUBMB Life 2019; 71(9): 1322 doi: 10.1002/iub.2039
24
Mariya A. Borisova, Kseniya M. Achasova, Ksenia N. Morozova, Evgeniya N. Andreyeva, Ekaterina A. Litvinova, Anna A. Ogienko, Maryana V. Morozova, Mariya B. Berkaeva, Elena Kiseleva, Elena N. Kozhevnikova. Mucin-2 knockout is a model of intercellular junction defects, mitochondrial damage and ATP depletion in the intestinal epithelium. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78141-4
25
Waliza Ansar, Shyamasree Ghosh. Biology of C Reactive Protein in Health and Disease. 2016; : 67 doi: 10.1007/978-81-322-2680-2_4
26
Gary R Lichtenstein, Dermot P B McGovern. Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current Status. The American Journal of Gastroenterology Supplements 2016; 3(3): 17 doi: 10.1038/ajgsup.2016.17
27
Javier P Gisbert, María Chaparro. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review. Journal of Crohn's and Colitis 2019; 13(3): 374 doi: 10.1093/ecco-jcc/jjy158
28
Yasmin Hadian, Daniel Fregoso, Chuong Nguyen, Michelle D. Bagood, Sara E. Dahle, Melanie G. Gareau, Roslyn Rivkah Isseroff. Microbiome‐skin‐brain axis: A novel paradigm for cutaneous wounds. Wound Repair and Regeneration 2020; 28(3): 282 doi: 10.1111/wrr.12800
29
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?. BIOCELL 2021; 45(3): 461 doi: 10.32604/biocell.2021.014332
30
Eniko Nagy, Ramona M. Rodriguiz, William C. Wetsel, Nancie J. MacIver, Laura P. Hale, Gunnar Loh. Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel Disease. PLOS ONE 2016; 11(4): e0152764 doi: 10.1371/journal.pone.0152764
31
Jihye Kim, Jaeyoung Chun, Changhyun Lee, Kyungdo Han, Seungho Choi, Jooyoung Lee, Hosim Soh, Kookhwan Choi, Seona Park, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim. Increased risk of idiopathic pulmonary fibrosis in inflammatory bowel disease: A nationwide study. Journal of Gastroenterology and Hepatology 2020; 35(2): 249 doi: 10.1111/jgh.14838
32
Valeriya S. Tsvetkova, Alexander S. Potapov, Elena L. Semikina, Andrey P. Fisenko, Maksim M. Lokhmatov, Andrey N. Surkov, Anton O. Anushenko, Elena A. Kopyltsova, Tatyana N. Budkina, Svetlana S. Akulova. Noninvasive assessment of ulcerative colitis activity in children. Russian Pediatric Journal 2021; 24(1): 12 doi: 10.46563/1560-9561-2021-24-1-12-19
33
Katrine Carlsen, Lene Buhl Riis, Henriette Elsberg, Louise Maagaard, Tine Thorkilgaard, Sveinung Wergeland Sørbye, Christian Jakobsen, Vibeke Wewer, Jon Florholmen, Rasmus Goll, Pia Munkholm. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis. Scandinavian Journal of Gastroenterology 2018; 53(7): 825 doi: 10.1080/00365521.2018.1482956
34
Dawn Queen, Amin A. Hedayat, Cynthia Magro, Larisa J. Geskin. An unusual cause of bilateral orbital swelling: Immunoglobulin G4–related orbital disease arising in a patient with ulcerative colitis. JAAD Case Reports 2019; 5(7): 634 doi: 10.1016/j.jdcr.2019.05.018
35
Matthew M. Philp, Howard M. Ross. The ASCRS Textbook of Colon and Rectal Surgery. 2016; : 771 doi: 10.1007/978-3-319-25970-3_45
36
Kimberly M. Anderson, C. Jane Welsh, Colin Young, Gwendolyn J. Levine, Sharon C. Kerwin, C. Elizabeth Boudreau, Ismael Reyes, Armando Mondragon, John F. Griffin, Noah D. Cohen, Jonathan M. Levine. Acute Phase Proteins in Cerebrospinal Fluid from Dogs with Naturally-Occurring Spinal Cord Injury. Journal of Neurotrauma 2015; 32(21): 1658 doi: 10.1089/neu.2015.3895
37
Anthony Croft, Anton Lord, Graham Radford-Smith. Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?. Journal of Crohn's and Colitis 2022; 16(7): 1089 doi: 10.1093/ecco-jcc/jjac014
38
Zhi-Zhi Wang, Ke Shi, Jie Peng. Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype. Biomedical Reports 2017; 6(4): 401 doi: 10.3892/br.2017.860
39
Maiss Reghefaoui, Tariladei S Peresuodei, Michell S Saavedra Palacios, Abhishek Gill, Chijioke Orji, Tiba Reghefaoui, Jihan Mostafa. The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease. Cureus 2023;  doi: 10.7759/cureus.48442
40
Kohki Okada, Hiroshi Itoh, Masaki Ikemoto. Serum complement C3 and α2-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients. Heliyon 2021; 7(3): e06554 doi: 10.1016/j.heliyon.2021.e06554
41
Heejeong Hong, Hyun-Kuk Song, Eun Sook Hwang, A. Reum Lee, Dong Soo Han, Seong-Eun Kim, Eok-Soo Oh. Up‐regulation of syndecan‐2 in proximal colon correlates with acute inflammation. The FASEB Journal 2019; 33(10): 11381 doi: 10.1096/fj.201900561R
42
Mary Kagujje, Winnie Mwanza, Paul Somwe, Lophina Chilukutu, Jacob Creswell, Monde Muyoyeta. Sensitivity and specificity of CRP and symptom screening as tuberculosis screening tools among HIV-positive and negative outpatients at a primary healthcare facility in Lusaka, Zambia: a prospective cross-sectional study. BMJ Open 2023; 13(4): e061907 doi: 10.1136/bmjopen-2022-061907
43
Abdurrahman Sahin, Hakan Artas, Yesim Eroglu, Nurettin Tunc, Gulcan Oguz, Ulvi Demirel, Orhan Poyrazoglu, Mehmet Yalniz, Ibrahim Bahcecioglu. A Neglected Issue in Ulcerative Colitis: Mesenteric Lymph Nodes. Journal of Clinical Medicine 2018; 7(6): 142 doi: 10.3390/jcm7060142
44
Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study. World Journal of Gastroenterology 2018; 24(42): 4798-4808 doi: 10.3748/wjg.v24.i42.4798
45
Nimisha Sarah Mathew, Serva Peddha Muthukumar, Bheemanakere Kempaiah Bettadaiah, Pradeep Singh Negi. Efficacy of a functional food ingredient from Ensete superbum Roxb. Cheesman peel in reducing the severity of ulcerative colitis in a murine model. Food & Function 2022; 13(6): 3732 doi: 10.1039/D1FO03365D
46
Fiona Yeaman, Anke Nguyen, Joshua Abasszade, Sanjana Gupta, Sally Bell, Gregory Moore. Assessing vitamin D as a biomarker in inflammatory bowel disease. JGH Open 2023; 7(12): 953 doi: 10.1002/jgh3.13010
47
Yan-Fei Wang, Ruo-Yu He, Chan Xu, Xiao-Ling Li, Yan-Fei Cao. Single-cell analysis identifies phospholysine phosphohistidine inorganic pyrophosphate phosphatase as a target in ulcerative colitis. World Journal of Gastroenterology 2023; 29(48): 6222-6234 doi: 10.3748/wjg.v29.i48.6222
48
Laura Francesca Pisani, Manuela Moriggi, Cecilia Gelfi, Maurizio Vecchi, Luca Pastorelli. Proteomic insights on the metabolism in inflammatory bowel disease. World Journal of Gastroenterology 2020; 26(7): 696-705 doi: 10.3748/wjg.v26.i7.696
49
Lizhi Zhang, Tsung-Teh Wu. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases. 2019; : 373 doi: 10.1007/978-3-030-15573-5_15
50
Sajjad Moradi, Reza Bagheri, Parsa Amirian, Mahsa Zarpoosh, Neda Cheraghloo, Alexei Wong, Mehdi Zobeiri, Mohammad Hassan Entezari. Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04400-w
51
Ping Jin, Kui Wang, Canhua Huang, Edouard C. Nice. Mining the fecal proteome: from biomarkers to personalised medicine. Expert Review of Proteomics 2017; 14(5): 445 doi: 10.1080/14789450.2017.1314786
52
Yu. M. Stepanov, I. V. Psareva, O. M. Tatarchuk, O. P. Petishko. DIAGNOSTIC VALUE OF LABORATORY AND FECAL BIOMARKERS FOR DETERMINING THE ACTIVITY OF ULCERATIVE COLITIS. Bulletin of Problems Biology and Medicine 2019; 4(1): 158 doi: 10.29254/2077-4214-2019-4-1-153-158-162
53
Sofija I. Lugonja, Ivana L. Pantic, Tamara M. Milovanovic, Vesna M. Grbovic, Bojana M. Djokovic, Željko D. Todorovic, Stefan M. Simovic, Raša H. Medovic, Nebojsa D. Zdravkovic, Natasa D. Zdravkovic. Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation. Medicina 2023; 59(3): 554 doi: 10.3390/medicina59030554
54
Federica Bellone, Carmela Morace, Giulia Impalà, Anna Viola, Alberto Lo Gullo, Maria Cinquegrani, Walter Fries, Alberto Sardella, Mariangela Scolaro, Giorgio Basile, Giovanni Squadrito, Giuseppe Mandraffino. Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?. Journal of Personalized Medicine 2023; 13(6): 947 doi: 10.3390/jpm13060947
55
Uday C Ghoshal, Sushmita Rai, Akshay Kulkarni, Ankur Gupta. Prediction of outcome of treatment of acute severe ulcerative colitis using principal component analysis and artificial intelligence. JGH Open 2020; 4(5): 889 doi: 10.1002/jgh3.12342
56
Gary R Lichtenstein, Dermot P B McGovern. Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current Status. The American Journal of Gastroenterology Supplements 2016; 3(3): 17 doi: 10.1038/ajgs.2016.17
57
Brigida Barberio, Renata D’Incà, Sonia Facchin, Marianna Dalla Gasperina, Cedric Arsenè Fohom Tagne, Romilda Cardin, Matteo Ghisa, Greta Lorenzon, Carla Marinelli, Edoardo Vincenzo Savarino, Fabiana Zingone. Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab. Inflammatory Bowel Diseases 2020; 26(5): 756 doi: 10.1093/ibd/izz195
58
Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination Survey. Preventive Medicine Reports 2023; 33: 102173 doi: 10.1016/j.pmedr.2023.102173
59
Petra Weimers, Dorit Vedel Ankersen, Pia Munkholm. Biomarkers in Inflammatory Bowel Diseases. 2019; : 271 doi: 10.1007/978-3-030-11446-6_22
60
Radislav Nakov. New markers in ulcerative colitis. Clinica Chimica Acta 2019; 497: 141 doi: 10.1016/j.cca.2019.07.033
61
Ekaterina A. Postovalova, Olga V. Makarova, Anna M. Kosyreva, Dzhuliia S. Dzhalilova. Hypoxia is a key mechanism for regulating inflammation in ulcerative colitis. Russian Open Medical Journal 2020; 9(1) doi: 10.15275/rusomj.2020.0101
62
Amandeep Singh, Uttam Kumar Mandal, Raj Kumar Narang. Development and In Vivo Evaluation of Pectin Based Enteric Coated Microparticles Loaded with Mesalamine and Saccharomyces boulardii for Management of Ulcerative Colitis. ASSAY and Drug Development Technologies 2022; 20(1): 22 doi: 10.1089/adt.2021.052
63
Nour Eissa, Hayam Hussein, Laëtitia Kermarrec, Omar Elgazzar, Marie-Helene Metz-Boutigue, Charles N. Bernstein, Jean-Eric Ghia. Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling. Biochemical Pharmacology 2017; 145: 102 doi: 10.1016/j.bcp.2017.08.013
64
Elizabeth A Spencer, Sonia M Davis, David R Mack, Brendan M Boyle, Anne M Griffiths, Neal S LeLeiko, Cary G Sauer, David J Keljo, James F Markowitz, Susan S Baker, Joel R Rosh, Robert N Baldassano, Maria Oliva-Hemker, Marian D Pfefferkorn, Anthony R Otley, Melvin B Heyman, Joshua D Noe, Ashish S Patel, Paul A Rufo, Keith Benkov, Jonathan Evans, Stephen Guthery, Michael Kappelman, Dedrick Moulton, Jennifer Strople, Boris Sudel, Prateek Wali, David Ziring, Vin Tangpricha, M Alison Marquis, Thomas D Walters, Margaret H Collins, Subra Kugathasan, Lee A Denson, Jeffrey S Hyams, Marla C Dubinsky. Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children. Inflammatory Bowel Diseases 2018; 24(6): 1335 doi: 10.1093/ibd/izy009
65
Belinda De Simone, Justin Davies, Elie Chouillard, Salomone Di Saverio, Frank Hoentjen, Antonio Tarasconi, Massimo Sartelli, Walter L. Biffl, Luca Ansaloni, Federico Coccolini, Massimo Chiarugi, Nicola De’Angelis, Ernest E. Moore, Yoram Kluger, Fikri Abu-Zidan, Boris Sakakushev, Raul Coimbra, Valerio Celentano, Imtiaz Wani, Tadeja Pintar, Gabriele Sganga, Isidoro Di Carlo, Dario Tartaglia, Manos Pikoulis, Maurizio Cardi, Marc A. De Moya, Ari Leppaniemi, Andrew Kirkpatrick, Vanni Agnoletti, Gilberto Poggioli, Paolo Carcoforo, Gian Luca Baiocchi, Fausto Catena. WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting. World Journal of Emergency Surgery 2021; 16(1) doi: 10.1186/s13017-021-00362-3
66
Jung Yoon Pyo, Sung Soo Ahn, Lucy Eunju Lee, Ha Na Choe, Jason Jungsik Song, Yong‐Beom Park, Sang‐Won Lee. Efficacy of the fibrosis index for predicting end‐stage renal disease in patients with antineutrophil cytoplasmic antibody‐associated vasculitis. International Journal of Clinical Practice 2021; 75(4) doi: 10.1111/ijcp.13929
67
T.D. Zvyagintseva, A.V. Yaroshenko . Biological diagnosis of inflammatory bowel disease: current ideas and future achievements.. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2021; 2021(1): 103 doi: 10.15407/internalmed2021.01.103
68
Raed M. Alsulaiman, Abdulaziz A. Al-Quorain, Fahad A. Al-Muhanna, Stanley Piotrowski, Ezzeddin A. Kurdi, Chittibabu Vatte, Ahmed A. Alquorain, Noorah H. Alfaraj, Abdulaziz M. Alrezuk, Fred Robinson, Alexa K. Dowdell, Turki A. Alamri, Lauren Hamilton, Hetal Lad, Hui Gao, Divya Gandla, Brendan J. Keating, Ryan Meng, Brian Piening, Amein K. Al-Ali. Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02904-2
69
Kenneth Daniel, Luis Vitetta, Maria A. Fiatarone Singh. Effects of olives and their constituents on the expression of ulcerative colitis: a systematic review of randomised controlled trials. British Journal of Nutrition 2022; 127(8): 1153 doi: 10.1017/S0007114521001999
70
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
71
Gemma Caliendo, Giovanna D'Elia, Jasmine Makker, Luana Passariello, Luisa Albanese, Anna Maria Molinari, Maria Teresa Vietri. Biological, genetic and epigenetic markers in ulcerative colitis. Advances in Medical Sciences 2023; 68(2): 386 doi: 10.1016/j.advms.2023.09.010
72
Yu. A. Khalitova, Yu. V. Myakisheva, S. E. Katorkin, P. S. Andreev, D. S. Gromova. Clinical and biochemical status of patients with ulcerative collitis. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 2022; (5): 66 doi: 10.20340/vmi-rvz.2022.5.CLIN.7
73
Weiwei Jiang, Xuhang Li. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Molecular Diagnosis & Therapy 2015; 19(3): 141 doi: 10.1007/s40291-015-0142-7
74
Alicja Derkacz, Pawel Olczyk, Katarzyna Komosinska-Vassev. Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/7451946
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345